𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer

✍ Scribed by Marc P. J. McCafferty; Roisin E. McNeill; Nicola Miller; Michael J. Kerin

Publisher
Springer US
Year
2009
Tongue
English
Weight
258 KB
Volume
116
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Electromagnetic fields alter the express
Electromagnetic fields alter the expression of estrogen receptor cofactors in breast cancer cells
✍ Rainer Girgert; Carsten GrΓΌndker; GΓΌnter Emons; Volker Hanf πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 125 KB πŸ‘ 1 views

## Abstract Breast cancer is the most common malignancy of women in Western societies. The increasing exposure to electromagnetic fields has been suspected to contribute to the rising incidence of breast cancer in industrialized countries. The majority of breast tumors is treated with the partial a

Relationship between estrogen receptor c
Relationship between estrogen receptor concentration and cytomorphometry in breast cancer
✍ Annamaria Guazzi; Cecilia Bozzetti; M. Irma Riva; Davide Zaffe; Giorgio Cocconi πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 406 KB πŸ‘ 2 views

This study aimed to evaluate the relationship between estrogen receptor (EH) concentration and cytomorphometric parameters in breast carcinoma. Primary breast cancer specimens were both imprinted on cytologic slides and submitted to ER determination with a dextran-coated charcoal method. Patients we

Relationship between proliferative activ
Relationship between proliferative activity and estrogen receptors in breast cancer
✍ Rosella Silvestrini; Maria Grazia Daidone; Giovanni Di Fronzo πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 441 KB πŸ‘ 2 views

The proliferative activity of breast cancer has been analyzed in relation to the hormonal characteristics of the host and of the tumor for 199 patients. The analyses of labeling index frequency distributions of estrogen receptor positive (ER') and negative (ER-) cancers from premenopausal and postme